Results for tag: "Cancer Stem Cell"

The Cancer Stem Cell (CSC) market is a subset of the larger stem cell market. CSCs are a type of stem cell that can cause cancer when they divide and grow uncontrollably. CSCs are believed to be responsible for the recurrence of cancer after treatment, and are the focus of much research into new treatments. CSCs are also being studied for their potential to be used in regenerative medicine. CSCs are being studied for their potential to be used in personalized medicine, where treatments are tailored to the individual patient. CSCs are also being studied for their potential to be used in drug discovery and development, as they can be used to test the effectiveness of new drugs. The CSC market is a rapidly growing field, with many companies investing in research and development. Companies such as Celgene, Novartis, and AstraZeneca are investing in CSC research, while companies such as Thermo Fisher Scientific and Bio-Rad are providing tools and services to support CSC research. Other companies such as StemCell Technologies and STEMCELL Technologies are providing products and services to support CSC research. Show Less Read more